Delivery Order SPE2DB24D2106-SPE2DB25FAWPB
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,435.28 by the Defense Logistics Agency (DLA) on August 6, 2025. The contract, with an ultimate completion date of August 27, 2025, covers the supply of Primaquine 26.3 mg tablets in quantities of 28 units. This delivery order was issued without a set-aside designation and represents work performed under DMS...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Primaquine 26.3 mg tablets (quantity 28). This firm fixed-price delivery order, valued at $2,091.04, carries an ultimate completion date of September 2, 2025, and was awarded on August 11, 2025, with no set-aside designation applied. The order falls under DMS Pharmaceutical Group's larger single-award...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 100 tablets of Primaquine 26.3 mg. The contract, valued at $2,322.40 with an ultimate completion date of September 5, 2025, was issued without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at $499.999...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $56,010.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Primaquine 26.3 mg tablets in quantities of 28 units. This firm fixed-price delivery order, issued on July 14, 2025, carries an ultimate completion date of August 4, 2025, and represents no set-aside designation. The award was issued under DMS Pharmaceutical Group's existing...
- The Defense Logistics Agency awarded a $5,290.80 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for the supply of Primaquine 26.3 mg tablets (100 count) with an ultimate completion date of June 6, 2025. This delivery order was issued without a set-aside designation and represents a single-award contract vehicle supporting the Department of Defense's pharmaceutical supply requirements. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in...
- The Defense Logistics Agency awarded a delivery order valued at $2,165.72 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Primaquine 26.3 mg tablets (28-count packaging). This firm fixed-price delivery order, issued on July 28, 2025, is scheduled for ultimate completion by August 18, 2025, with performance taking place at the vendor's Park Ridge facility. The award carries no set-aside designation, allowing...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $6,873.72, is for the delivery of 14-count packs of 26.3 mg Primaquine tablets. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,120.20 contract is for the delivery of Primaquine 26.3 mg tablets to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at up to $499,999,999, which allows the...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $2,243.52 for the supply of Primaquine 26.3 mg tablets to the Defense Logistics Agency (DLA). The award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This single-award IDC allows the DLA to issue firm fixed-price delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $12,697.92 firm fixed price delivery order is for the supply of Primaquine 26.3 mg tablets. It is not associated with a set-aside program. DMS Pharmaceutical Group Inc. holds a single-award indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31,...
- SPE2DB24D2106Indefinite Delivery Contract
- SPE2DB24D2106-SPE2DB25FAWPBDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, received a delivery order award from the Defense Logistics Agency (DLA) on September 18, 2025, for Primaquine 26.3 mg tablets (100-count units) valued at $2,345.08. This firm fixed-price delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, a $499.999 billion vehicle that enables the agency to procure a comprehensive range of pharmaceutical products to support medical supply needs at military healthcare facilities worldwide. The delivery order carries an ultimate completion date of September 19, 2025, with performance to occur in Conshohocken, PA. No set-aside designation was applied to this award. Primaquine is an antimalarial medication used for treating and preventing malaria, making this delivery relevant to the Department of Defense's global health readiness requirements for personnel deployed to malaria-endemic regions. DMS Pharmaceutical Group's established role as a key supplier within the federal pharmaceutical supply chain, combined with its woman-owned small business status and extensive contract portfolio with military health facilities, positions it as a reliable vendor for critical pharmaceutical distribution to Department of Defense healthcare sites. The company has consistently secured contracts for diverse pharmaceutical products ranging from specialty medications to vaccines and medical supplies across its DLA relationships.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 9/18/25 |